Before medical science can bioengineer human organs in a lab for therapeutic use, two remaining hurdles are ensuring genetic stability — so the organs are free from the risk of tumor growth — and producing organ tissues of sufficient volume and size for viable transplant into people. Scientists now report achieving both goals with a new production method for bioengineered human gut and liver tissues.